Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

Am J Hematol · 2022 · PMC9349555 · PMID 35702878

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

did not reach statistical significancep = .074so close (0.05 < p ≤ 0.1)

Having received at least one dose of SARS‐CoV‐2 vaccine was protective in univariable analysis (HR 0.53 [95% CI 0.29–0.96, p = .036]), but did not reach statistical significance in multivariable analysis (HR 0.58 [95% CI 0.32–1.05, p = .074]) (eFigure 2a, Table 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.